Skip to search formSkip to main contentSkip to account menu

cadrofloxacin

Known as: 1-cyclopropyl-8-(difluoromethoxy)-6-fluoro-7-[(3S)-3-methylpiperazin-1-yl]-4-oxo-quinoline-3-carboxylic acid, caderofloxacin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Objective To evaluate the impact of caderofloxacin lactate on reproductive capability of female rats and growth of fetal rats… 
2010
2010
Objective:To establish a method for the content determination of caderofloxacin in Caderofloxacin Lactate Injection by HPLC… 
2009
2009
Objective To establish a sensitive and specific RP-HPLC method for determination caderofloxacin concentration in healthy human… 
2009
2009
Objective: To evaluate the safety and tolerance of single-dose caderofloxacin lactate injection in Chinese healthy volunteers… 
2008
2008
OBJECTIVE To synthesize caderofloxacin,a fluoroquinolone antimicrobial agent.METHODS Caderofloxacin was prepared from 3… 
2007
2007
Aim:To investigate the effect of caderofloxacin on CYP450 activity in rats.Methods:Six probes(theophylline,midazolam… 
2006
2006
The invention relates to a powder injection containing caderofloxacin lactate. The injection of the invention consists of active… 
2004
2004
Clinical pharmacological studies of a novel fluoroquinolone antibacterial drug, cadrofloxacin, were performed in 12 surgical… 
2003
2003
AIM To analyse the main impurity of caderofloxacin. METHODS The impurity of caderofloxacin was analysed and determinated by RP…